Project Number: 3091-22000-033-09-R
Project Type: Reimbursable Cooperative Agreement
Start Date: Mar 15, 2011
End Date: Mar 14, 2015
Our ultimate goal is to see if we can generate tools to manipulate diapause in members of the Heliothis/Helicoverpa complex. There are a number of ways in which diapause could be manipulated for controlling insects, but few such tactics have thus far been exploited. In working toward this goal with moths in the Heliothis/Helicoverpa complex, we have in past work characterized a neuropeptide, DH, that is highly effective in breaking diapause, and we have now defined the active core of the peptide and developed a hyperpotent agonist that is nearly 50-fold more potent than the native hormone in breaking diapause. This DH agonist also has the capacity to prevent diapause. In addition, we will develop a DH antagonist capable of blocking the diapause-terminating action of DH. Thus, the stage will be set for preventing diapause, as well as both advancing and delaying its termination. It is the goal of this proposal to further enhance the potency of these agents, generate new agents with even greater biostability and bioavailability with the aim of using these tools to disrupt the diapause response of these important agricultural pests.
The work will involve the design and synthesis of biostable, bioavailable analogs of the neuropeptide DH, which regulates aspects of the state of diapause in heliothines, capable of either overstimulating or blocking the action of this hormone. These analogs will be analyzed by traditional bioassays and in an expressed DH heliothine receptor assay for effectiveness by the cooperating laboratory. These initial assays will be used to guide the development of second generation analogs with further enhanced activity/properties. Analogs with optimal activity and biostable properties will be further investigated for their ability to manipulate diapause in the Heliothis/Helicoverpa complex as a means of controlling these pest insects.